In an era of rapidly proliferating, precisely targeted treatments, every cancer case has to be played by ear.
NYT > Research
Andrew Levy’s parents knew that the rare and deadly cancer in his blood could not be beaten, so they began to prepare for the worst. Then something mysterious happened.
Most clinical trials for cancer drugs are failures. But for a handful of patients, a drug proves to be nearly a cure. What can science learn from these “exceptional responders”?
New research on potential allergens fits with a wider hypothesis that complete avoidance of risky substances doesn’t work well.
Old but only recently published research increases a concern that when it comes to nutrition, personal beliefs can trump science.
Research points to both advantages and disadvantages. In the end, it’s a personal choice.
The United States does worse than about two dozen other industrialized nations in this crucial measure of public health.
In the early 20th century, the German biochemist Otto Warburg believed that tumors could be treated by disrupting their source of energy. His idea was dismissed for decades — until now.